Download this White Paper
Fina Biosolutions (FinaBio) has a clear mission: Make conjugate vaccines more affordable. FinaBio is unique in that it is a privately held, self-funded biotechnology company. The company needed to implement key strategies and solutions for cGMP manufacturing of EcoCRM®, FinaBio’s CRM197 (genetically detoxified diphtheria toxin) which is globally used as the carrier protein in conjugate vaccines.
Download this insightful article to learn more about their success story. Learn about:
Offered Free by: Scorpius BioManufacturing
See All Resources from: Scorpius BioManufacturing
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.